US Stock Market Move | Teladoc Health (TDOC.US) has surged by over 9.7%. The well-known short-selling agency Citron Research has made a rare bullish comment on it.

On Wednesday, the stock price of Teladoc Health (TDOC.US), a US-based telemedicine company, rose. At the time of writing, the stock price had increased by over 9.7%, reaching $9.185. In terms of news, last week the well-known short-selling institution Citron Research made a rare bullish comment, stating that they were "not mistaken, just early", and reaffirming their confidence in the long-term potential of the company. Teladoc has been deeply involved in the fields of digital healthcare and virtual consultations in recent years. Despite the stock price falling from its peak during the COVID-19 pandemic, institutional analysts point out that with the acceleration of the digital transformation of healthcare insurance and corporate health plans, the company is expected to usher in new growth opportunities.